Skip To Main Content
Mario Bargetzi on Muck Rack

Mario Bargetzi

As seen in: Swiss Medical Weekly
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Mario

Contact Mario, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Diagnosis and treatment of follicular lymphoma: an update

|
By Mario Bargetzi, Sergio Cogliatti, Pierre-Yves Dietrich, Michel A. Duchosal, Andreas Lohri, Reto Baumann, Jeroen Goede, Felicitas Hitz, Carolin Konermann, Ulrich Mey, Urban Novak, Alexandros Papachristofilou, Frank Stenner, Christian Taverna, Thilo Zander, Christoph Renner
| Swiss Medical Weekly Verified
This text is only available as PDF .
Open in Who Shared Issue with article?

Swiss Medical Weekly - Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016

|
By Jakob Passweg, Marc Ansari, Jörg Halter, Helen Baldomero, Gabriela M. Baerlocher, Mario Bargetzi, Yves Chalandon, Michel A. Duchosal, Sabine Gerull, Tayfun Güngör, Dominik Heim, Urs Hess, Kurt Leibundgut, Stavroula Masouridi-Levrat, Antonia Müll
| Swiss Medical Weekly Verified
Transplantation of haematopoietic stem cells (HCT) is today an established therapy and has expanded rapidly over recent decades. It is used for many severe acquired or congenital disorders of the haematopoietic system and for chemo, radio or immunosensitive malignancies. Stem cells from bone marrow, peripheral blood or cord blood are used, and may be derived from the patients themselves for autologous HCT or from siblings, other family members or unrelated donors for allogeneic HCT [1–6].
Open in Who Shared Issue with article?
See all 2 articles